Home
Conditions
Pheochromocytoma

Clinical trial condition

Pheochromocytoma

Explore clinical trials studying Pheochromocytoma. Study availability and eligibility vary by location and protocol.

71 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Pheochromocytoma trial results

Recruiting

Diagnosis of Pheochromocytoma

NCT00004847

Conditions: Endocrine Disease, Endocrine Diseases, Endocrine System Diseases, +8 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

NCT06427798

Conditions: Gastrointestinal Neuroendocrine Tumors, Neoplasms, Neoplasms by Histologic Type, +8 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

An Experimental Study of Belzutifan Impact on Catecholamine Metabolism

NCT07680205

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations: Cambridge University Hospitals NHS Foundation Trust Cambridge, Cambridgeshire, United Kingdom

View Trial Details

Recruiting

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

NCT06607692

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +57 more
Locations: HM Monteprincipe Boadilla del Monte, Madrid, Spain

View Trial Details

Recruiting

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

NCT00107289

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +10 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

NCT05636618

Conditions: Bronchial Neuroendocrine Tumor, Central Nervous System Neoplasms, Gastro-enteropancreatic neuroendocrine tumor, +17 more
Locations: Mayo Clinic Jacksonville, Florida, United States

Biogenix Molecular Miami, Florida, United States

The University of Chicago Chicago, Illinois, United States

University of Iowa Iowa City, Iowa, United States

View all 19 locations

View Trial Details

Recruiting

Adrenal Tumors - Pathogenesis and Therapy

NCT00669266

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +21 more
Locations: University of Wuerzburg Würzburg, Germany

View Trial Details

Recruiting

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

NCT03206060

Conditions: Cardiovascular Diseases, Hypertension, Neoplasms, +9 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT04119024

Conditions: Acral Melanoma, Adenocarcinoma, Adenocarcinoma of Lung, +59 more
Locations: City of Hope Duarte, California, United States

UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Stanford Cancer Institute Stanford, California, United States

View Trial Details

Recruiting

In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

NCT05636540

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Pheochromocytoma

Pheochromocytoma trial results

Related conditions